Nonalcoholic fatty liver disease (NAFLD) in children

Nonalcoholic fatty liver disease (NAFLD) is common in obese children and is a growing problem, given the increase in prevalence of obesity. NAFLD is also associated with diabetes, insulin resistance, hypercholesterolemia, and hypertriglyceridemia. Although mostly benign, some children with NAFLD develop fibrosis and cirrhosis, which necessitates close monitoring. Chronically elevated plasma liver enzyme levels is the most frequent finding. Ultrasound (US) examination allows confirmation of the diagnosis and it is useful for the follow-up. Gradual and sustained weight reduction is a management option that is worth trying initially. Other modalities of management, although interesting, await evidence as well as information on long-term benefits and effects. Sustained increase of transaminases despite weight reduction is a cause for concern and may require a liver biopsy both to assess severity of liver damage and for prognostic purposes. Curr Opin Pediatr 2002, 14:593–600 © 2002 Lippincott Williams &

[1]  E. Roberts,et al.  Nonalcoholic steatohepatitis in children , 2003, Current gastroenterology reports.

[2]  G. Pacini,et al.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.

[3]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[4]  E. Elliott,et al.  Evidence based management of childhood obesity , 2001, BMJ : British Medical Journal.

[5]  Marco Zoli,et al.  Metformin in non-alcoholic steatohepatitis , 2001, The Lancet.

[6]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[7]  M. Tremblay,et al.  Secular trends in the body mass index of Canadian children. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[8]  C. García-Monzón,et al.  Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. , 2000, Journal of hepatology.

[9]  J. Lavine Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. , 2000, The Journal of pediatrics.

[10]  R. Sokol The chronic disease of childhood obesity: the sleeping giant has awakened. , 2000, The Journal of pediatrics.

[11]  A. Franzese,et al.  Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. , 2000, The Journal of pediatrics.

[12]  W. Dietz,et al.  Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. , 2000, The Journal of pediatrics.

[13]  T. Cole,et al.  Establishing a standard definition for child overweight and obesity worldwide: international survey , 2000, BMJ : British Medical Journal.

[14]  J. Reilly,et al.  Epidemic of obesity in UK children , 1999, The Lancet.

[15]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.

[16]  H. Cortez‐Pinto,et al.  Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. , 1999, Gastroenterology.

[17]  R. Strauss Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III) , 1999 .

[18]  L. Kaplan Leptin, obesity, and liver disease. , 1998, Gastroenterology.

[19]  C. Day,et al.  Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. , 1998, Journal of hepatology.

[20]  C. Day,et al.  Hepatic steatosis: Innocent bystander or guilty party? , 1998, Hepatology.

[21]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[22]  D B Allison,et al.  Body mass index as a measure of adiposity among children and adolescents: a validation study. , 1998, The Journal of pediatrics.

[23]  F. Gordon,et al.  AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection , 1998, American Journal of Gastroenterology.

[24]  F. Brunetti,et al.  Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population) , 1997, Digestive Diseases and Sciences.

[25]  L Dalla Palma,et al.  Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.

[26]  F. Gottrand,et al.  Acute steatosis in an 8-year-old boy with insulin-dependent diabetes mellitus. , 1997, Journal of pediatric gastroenterology and nutrition.

[27]  K. Tanikawa,et al.  Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. , 1997, Journal of hepatology.

[28]  M. Uchiyama,et al.  The relationship between fatty liver and hyperinsulinemia in obese Japanese children. , 1997, Journal of pediatric gastroenterology and nutrition.

[29]  G. Takada,et al.  Serum alanine aminotransferase activity in obese children , 1997, Acta paediatrica.

[30]  W. Kim,et al.  Recurrence of nonalcoholic steatohepatitis following liver transplantation. , 1996, Transplantation.

[31]  A. Lonardo,et al.  Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. , 1996, Gastroenterology.

[32]  G. Gores,et al.  Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study , 1996, Hepatology.

[33]  G. Takada,et al.  Effect of weight reduction on serum transaminase activities in children with simple obesity. , 1996, The Journal of pediatrics.

[34]  M. Bennett,et al.  The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.

[35]  Randall G. Lee,et al.  Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler , 1995, Hepatology.

[36]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.

[37]  P. Vajro,et al.  Persistent hyperaminotransferasemia resolving after weight reduction in obese children. , 1994, The Journal of pediatrics.

[38]  W. Dietz,et al.  Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services. , 1994, The American journal of clinical nutrition.

[39]  F. Schaffner,et al.  Effect of weight reduction on hepatic abnormalities in overweight patients. , 1990, Gastroenterology.

[40]  K. Tsunamoto,et al.  Fatty liver and its fibrous changes found in simple obesity of children. , 1984, Journal of pediatric gastroenterology and nutrition.

[41]  G. Bray Overweight Is Risking Fate , 1984, The Western journal of medicine.

[42]  H. Greene,et al.  Steatohepatitis in obese children: a cause of chronic liver dysfunction. , 1983, The American journal of gastroenterology.

[43]  D. Berkowitz METABOLIC CHANGES ASSOCIATED WITH OBESITY BEFORE AND AFTER WEIGHT REDUCTION. , 1964, JAMA.

[44]  C. M. Leevy FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATURE , 1962 .

[45]  W. Wheeler Recent advances in pediatrics. , 1946, The Ohio journal of science.

[46]  U. Visco-Comandini,et al.  Metformin in non-alcoholic steatohepatitis , 2002, The Lancet.

[47]  R. D. de Knegt Non-alcoholic steatohepatitis: clinical significance and pathogenesis. , 2001, Scandinavian journal of gastroenterology. Supplement.

[48]  F. Gürakan,et al.  Obesity: a cause of steatohepatitis in children , 2000, American Journal of Gastroenterology.

[49]  G. Bray,et al.  Therapeutic controversy: Obesity--a modern-day epidemic. , 1999, The Journal of clinical endocrinology and metabolism.

[50]  L. Aronne Drug Therapy for Obesity—A Therapeutic Option? , 1999 .

[51]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.